Cardiometabolic Effects of Fatty Kidney Disease

Saturday, May 14, 2022

4:45 PM – 5:45 PM

Location: Main Stage - Sapphire IJMN (Level 4)

Moderator(s)

Sumeet Jain, MD
Endocrinologist
Rush University Medical Center
Chicago, Illinois, United States

Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Speaker(s)

Christian W. Mende, MD
Clinical Professor of Medicine
UCSD
La Jolla, California, United States

Disclosure: Disclosure information not submitted.

PDF Slides

Learning Objectives:

Recognize what Fatty Kidney Disease is as a distinct clinical entity.
Identify the concept of ectopic fat as a driver of metabolic disease in many organs
Prepare for imaging and therapies that will give Fatty Kidney Disease a place alongside Fatty Liver Disease

Participants should be aware of the following financial/non-financial relationships:

Sumeet Jain, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Christian W. Mende, MD: Bayer , AstraZeneca, Lilly, Boehringer (Individual(s) Involved: Self): Consulting Fees (e.g., advisory boards), Honorarium